Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)Enrique Grande, Rocio García‐Carbonero, Luís Ortega et al.|Annals of Oncology|2015Cited by 157